Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
08/2005
08/30/2005US6936613 for treatment of central nervous system diseases and disorders, which are responsive to modulation of the Gamma amminobutyric acid (GABA) receptor complex, and for inducing and maintaining anesthesia, sedation and muscle relaxation
08/30/2005US6936611 Serine protease inhibitors
08/30/2005US6936600 Oxidoreductase enzyme inhibitors such as (R)-1-[4-(2-methyl-4-phenyl-5,8-dihydro-6H-pyrido[3,4-d]pyrimidin-7-yl)-pyrimidin-2-yl-ethanol, used as antidiabetic agents
08/30/2005US6936570 herbicides
08/25/2005WO2005077944A1 Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain
08/25/2005WO2005077941A2 Candesartan cilexetil polymorphs
08/25/2005WO2005077940A1 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
08/25/2005WO2005077939A1 Substituted benzimidazoles and their use for inducing apoptosis
08/25/2005WO2005077938A1 Vanilloid receptor ligands and their use in treatments
08/25/2005WO2005077923A1 Maleimide resin with cyanurate core
08/25/2005WO2005077915A1 Pyridazinones as antagonists of a4 integrins
08/25/2005WO2005077914A1 PYRIDAZINONE UREAS AS ANTAGONISTS OF α4 INTEGRINS
08/25/2005WO2005077905A1 Fused-ring 4-oxopyrimidine derivative
08/25/2005WO2005077900A1 Bicyclic amide derivatives
08/25/2005WO2005077344A2 Hydantoin derivatives as inhibitors of cellular necrosis
08/25/2005WO2005076854A2 Pyrimidinone compounds useful as kinase inhibitors
08/25/2005WO2005066158A3 An improved process for the synthesis of losartan potassium
08/25/2005WO2005051942A8 Indazole compounds and methods of use thereof as protein kinase inhibitors
08/25/2005WO2004108687A3 Nitrogen-containing heteroaryl derivatives for the treatment of hcv-infection
08/25/2005WO2004106493A3 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
08/25/2005US20050187390 Bicyclic heteroaryl derivatives
08/25/2005US20050187284 Integrin receptor inhibitors
08/25/2005US20050187279 Indazole derivatives useful for the treatment of eating disorders, weight gain, obesity, abnormalities in reproduction and sexual behavior, thyroid hormone secretion, diuresis and water/electrolyte homeostasis, sensory processing, memory, sleeping, arousal, anxiety, depression, seizure etc.
08/25/2005US20050187277 Protein tyrosine phosphatase inhibitors; diseases including type I and type II diabetes, cancer, autoimmune diseases, AIDS; imidazole, oxazole and thiazole derivatives; e.g. 4-(4-(2,4-dichloro-phenyl)-2-(2-(3'-methanesulfonyl-biphenyl-4-yl)-(E)-vinyl)-imidazol-1-ylmethyl)-benzoic acid
08/25/2005US20050187275 Preterm labor, premature birth, dysmenorrhea, inappropriate secretion of vasopressin, congestive heart failure, arterial hypertension, liver cirrhosis, nephrotic syndrome and ocular hypertension; 3-(5-((3-chlorobenzyl)sulfanyl)-4-(3-methoxypropyl)-4H-1,2,4-triazol-3-yl)-N-(2-methoxybenzyl)propanamide
08/25/2005US20050187236 Nitrogen-containing aromatic derivatives
08/25/2005US20050187217 Sodium channel modulators; pain relievers; treating epilepsy, neurodegenerative disorders, psychiatric disorders, arrhythmia, movement disorders, autoimmune diseases, and incontinence; fused ring 4-aminopyrimidines e.g. 4-amino-5,6,7,8-tetrahydroquinazolines
08/25/2005US20050187110 Novel herbicides
08/25/2005US20050186446 Phosphorescence; personal computer, portable telephone, television receiver
08/25/2005CA2556239A1 Vanilloid receptor ligands and their use in treatments
08/25/2005CA2555685A1 Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain
08/25/2005CA2555594A1 Pyridazinones as antagonists of a4 integrins
08/25/2005CA2555294A1 Candesartan cilexetil polymorphs
08/25/2005CA2555227A1 Pyridazinone ureas as antagonists of .alpha.4 integrins
08/25/2005CA2554378A1 Bicycloamide derivative
08/25/2005CA2553630A1 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
08/25/2005CA2536622A1 Inhibitors of cellular necrosis
08/24/2005EP1566378A1 Isoindoline derivative
08/24/2005EP1565456A1 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
08/24/2005EP1565455A1 Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
08/24/2005EP1565454A1 Pyrazine compounds as crf modulators
08/24/2005EP1565446A1 Chk-, pdk- and akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
08/24/2005EP1565445A1 Novel process for the preparation of imidazolyl compounds
08/24/2005EP1565442A1 Pyridine derivatives as cb2 receptor modulators
08/24/2005EP1565436A2 3-aminopyrrolidine derivatives as modulators of chemokine receptors
08/24/2005EP1458713B1 Indolinone derivatives useful as protein kinase inhibitors
08/24/2005EP1370558B1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists
08/24/2005EP1343789B1 Tricyclic derivatives of indole with antiangiogenic activity
08/24/2005EP1218341B1 Sulfonyl carboxamide derivatives, method for their production and their use as medicaments
08/24/2005EP1214304B1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes
08/24/2005EP1124804B1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors
08/24/2005EP1019075B1 Beta 2-adrenergic receptor agonists
08/24/2005CN1659931A 场致发光器件 Electroluminescent devices
08/24/2005CN1659456A Filters for electronic displays
08/24/2005CN1659239A Yellow anionic disazo dyes
08/24/2005CN1659151A 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/24/2005CN1659148A Aryloximes
08/24/2005CN1659143A Nitrogen-containing heteroaryl compounds having HIV integrase inhibitory activity
08/24/2005CN1659141A 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders
08/24/2005CN1658847A Use of EP4 receptor ligands in the treatment of IL-6 involved diseases
08/24/2005CN1658759A Insecticidal amides with nitrogen-containing benzo-fused bicyclic ring systems
08/24/2005CN1657523A Cyclic compounds
08/24/2005CN1216056C Sulfamato hydroxamic acid metalloprotease inhibitor
08/24/2005CN1215835C Ketone derivatives and medical use thereof
08/23/2005US6933391 Methods of synthesizing heteroatom-bearing ligands and intermediate used therefor
08/23/2005US6933314 Integrin receptor inhibitors
08/23/2005US6933313 Carbazoles with hydroxyfunctional amide (hydroxamic or esters) are for inhibiting sPLA2 mediated release of fatty acids for treatment of conditions such as septic shock
08/23/2005US6933312 Pyrazole derivatives
08/23/2005CA2138288C Substituted azabicycloheptane derivatives, their preparation and use
08/18/2005WO2005075600A1 Organic element for electroluminescent devices
08/18/2005WO2005075461A1 Imidazolo-5-yl-2-anilinopyrimidines as agents for the inhibition of cell proliferation
08/18/2005WO2005075439A1 Quinazoline derivatives
08/18/2005WO2005075437A1 Pyridazinone derivatives and their use as pde4 inhibitors
08/18/2005WO2005075436A2 Novel inhibitors of glutaminyl cyclase
08/18/2005WO2005075426A1 Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof
08/18/2005WO2005075422A1 Synthesis methods and intermediates for the manufacture of rizatriptan
08/18/2005WO2005074919A1 Diurea derivatives
08/18/2005WO2005040345A3 4-azole substituted imidazole compositions useful as inhibitors or c-met receptor tyrosine kinase
08/18/2005WO2005030794A3 Hemiasterlin derivatives and uses thereof
08/18/2005WO2005013909A3 Novel cathepsin k inhibitors
08/18/2005WO2004100873A3 Compounds, compositions, and methods
08/18/2005US20050182114 1,4-dioxane solvate; crystal structure
08/18/2005US20050182083 Heterocyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-kB activity and use thereof
08/18/2005US20050182073 Controlling microorganisms; e.g. agricultural fungicides; preservatives for e.g. lubricants, paints; chemical intermediates and synthesis thereof
08/18/2005US20050182067 Vanilloid receptor ligands and their use in treatments
08/18/2005US20050182061 Phthalimide compounds useful as protein kinase inhibitors
08/18/2005US20050182054 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
08/18/2005US20050182047 Treatment of demyelinating disorders
08/18/2005US20050182045 Fused ring 4-oxopyrimidine derivative
08/18/2005US20050182043 4-amino-6-cycloalkyloxy-7-substituted quinazolines; inhibition of signal transduction mediated by tyrosine kinases; antitumor agents, respiratory system and gastrointestinal disorders
08/18/2005US20050180953 peptides derivatives as an agent inducing cells differentiation and in particular, to their use in antitumor noncytotoxic therapy; melanoma; most preferred compound used in the present invention is 4-[N-(2-imidazol-4-yl)ethyl)carbamoyl]butyric acid (Dicarbamine (reg) )
08/18/2005CA2555313A1 Heparanase inhibitors and uses thereof
08/18/2005CA2554809A1 Novel n-alkyl thiourea-and thioamide-substituted imidazolyl inhibitors and glutaminyl cyclase
08/18/2005CA2554076A1 Imidazolo-5-yl-2-anilinopyrimidines as agents for the inhibition of cell proliferation
08/18/2005CA2553652A1 Synthesis methods and intermediates for the manufacture of rizatriptan
08/18/2005CA2553243A1 Pyrrolo pyrimidine derivatives useful for treating proliferative diseases
08/18/2005CA2551566A1 Diurea derivatives
08/17/2005EP1562938A1 Heteroaryl-pyrimidine derivatives as jak inhibitors
08/17/2005EP1562936A2 Therapeutic piperazine compounds
08/17/2005EP1562935A1 Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors